|
PT65486B
(en)
|
1975-08-28 |
1978-03-24 |
Lilly Co Eli |
Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
|
|
JPH0649066B2
(ja)
|
1985-02-14 |
1994-06-29 |
積水化学工業株式会社 |
医療用粘着シ−トもしくはテ−プ
|
|
FR2687574B1
(fr)
*
|
1992-02-25 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.
|
|
US5349068A
(en)
|
1992-04-15 |
1994-09-20 |
Sterling Winthrop Inc. |
1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
|
|
JPH07188017A
(ja)
|
1993-09-30 |
1995-07-25 |
Souyaku Gijutsu Kenkyusho:Kk |
チアジアゾール誘導体を含有する抗ウイルス剤
|
|
US5453433A
(en)
|
1994-05-13 |
1995-09-26 |
Sterling Winthrop Inc. |
Thiadiazoles and antipicornaviral compositions
|
|
US5552422A
(en)
|
1995-01-11 |
1996-09-03 |
Merck Frosst Canada, Inc. |
Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
|
|
JPH11106340A
(ja)
*
|
1997-10-02 |
1999-04-20 |
Sumitomo Pharmaceut Co Ltd |
Ｓｔａｔ６活性化阻害剤
|
|
US6258831B1
(en)
|
1999-03-31 |
2001-07-10 |
The Procter & Gamble Company |
Viral treatment
|
|
AR044519A1
(es)
|
2003-05-02 |
2005-09-14 |
Novartis Ag |
Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
|
|
GB0321003D0
(en)
|
2003-09-09 |
2003-10-08 |
Angeletti P Ist Richerche Bio |
Compounds, compositions and uses
|
|
US7229480B2
(en)
|
2004-02-13 |
2007-06-12 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
JP2009535386A
(ja)
|
2006-05-03 |
2009-10-01 |
アストラゼネカ アクチボラグ |
チアゾール誘導体および抗腫瘍剤としてのその使用
|
|
GB0716292D0
(en)
|
2007-08-21 |
2007-09-26 |
Biofocus Dpi Ltd |
Imidazopyrazine compounds
|
|
HUE025976T2
(en)
|
2007-09-27 |
2016-05-30 |
Fund Centro Nac De Investig Oncologicas Carlos Iii |
Imidazolothiadiazoles for use as protein kinase inhibitors
|
|
AU2009275544B2
(en)
*
|
2008-07-29 |
2013-09-12 |
Merck Patent Gmbh |
Imidazothiadiazoles derivatives
|
|
US8629153B2
(en)
*
|
2008-09-03 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Use of quinazoline derivatives for the treatment of viral diseases
|
|
WO2010103130A2
(en)
|
2009-03-13 |
2010-09-16 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Novel bicyclic heterocycles
|
|
NZ595674A
(en)
|
2009-04-02 |
2012-12-21 |
Ct Nac Investigaciones Oncologicas Cnio |
Imidazo[2,1-b][1,3,4]thiadiazole derivatives
|
|
GB201012889D0
(en)
|
2010-08-02 |
2010-09-15 |
Univ Leuven Kath |
Antiviral activity of novel bicyclic heterocycles
|
|
GB201015411D0
(en)
|
2010-09-15 |
2010-10-27 |
Univ Leuven Kath |
Anti-cancer activity of novel bicyclic heterocycles
|
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
|
GB201115665D0
(en)
|
2011-09-09 |
2011-10-26 |
Univ Leuven Kath |
Autoimmune and inflammatory disorder therapy
|
|
WO2013052845A1
(en)
|
2011-10-05 |
2013-04-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
|
EP3409666A3
(en)
|
2012-06-07 |
2019-01-02 |
Georgia State University Research Foundation, Inc. |
Seca inhibitors and methods of making and using thereof
|
|
EP2920177A1
(en)
|
2012-11-19 |
2015-09-23 |
Novartis AG |
Compounds and compositions for the treatment of parasitic diseases
|
|
JP6298830B2
(ja)
|
2012-12-20 |
2018-03-20 |
ユーシービー バイオファルマ エスピーアールエル |
治療用に活性なピラゾロ−ピリミジン誘導体
|
|
CN105228983A
(zh)
|
2013-05-30 |
2016-01-06 |
普莱希科公司 |
用于激酶调节的化合物及其适应症
|
|
JP6509238B2
(ja)
|
2014-01-22 |
2019-05-08 |
キュロヴィル・アクチボラグ |
治療に有用なピラゾロ［１，５−ａ］ピリミジン−７−アミン誘導体
|
|
US10471028B2
(en)
|
2014-06-13 |
2019-11-12 |
University Of Rochester |
Small molecule efflux pump inhibitors
|
|
GB201410816D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201410815D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201410817D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D |
Therapeutic agents
|
|
US10278942B2
(en)
|
2015-03-11 |
2019-05-07 |
Peloton Therapeutics, Inc. |
Compositions for use in treating pulmonary arterial hypertension
|
|
US10512626B2
(en)
|
2015-03-11 |
2019-12-24 |
Peloton Therapeautics, Inc. |
Compositions for use in treating glioblastoma
|
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
|
WO2016168510A1
(en)
|
2015-04-17 |
2016-10-20 |
Peloton Therapeutics, Inc. |
Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
|
|
AU2016284638B2
(en)
|
2015-06-24 |
2020-01-23 |
Curovir Ab |
Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy
|
|
EP3118198A1
(en)
|
2015-07-13 |
2017-01-18 |
MMV Medicines for Malaria Venture |
Anti-malarial agents
|
|
US10980755B2
(en)
|
2015-09-10 |
2021-04-20 |
The Regents Of The University Of California |
LRH-1 modulators
|
|
US20190048421A1
(en)
|
2015-09-21 |
2019-02-14 |
The Board Of Regents Of The University Of Texas System |
Biomarkers of response to hif-2-alpha inhibition in cancer and methods for the use thereof
|
|
GB201517264D0
(en)
|
2015-09-30 |
2015-11-11 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201517263D0
(en)
|
2015-09-30 |
2015-11-11 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201521767D0
(en)
|
2015-12-10 |
2016-01-27 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D |
Therapeutic agents
|
|
WO2017147526A1
(en)
|
2016-02-26 |
2017-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
|
US10138248B2
(en)
|
2016-06-24 |
2018-11-27 |
Incyte Corporation |
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
|
|
US20190358196A1
(en)
|
2016-07-27 |
2019-11-28 |
Henry C. Lowe |
Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant
|